BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
- Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
- Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
- As a result, the Company requested approval from the Ontario Securities Commission for an extension of the MCTO and such extension was granted by the OSC until May 13, 2024.
- Except as herein disclosed, there are no material changes to the information contained in the Default Announcement.